Retroviral Coexpression of Thymidylate Synthase and Dihydrofolate Reductase Confers Fluoropyrimidine and Antifolate Resistance
- 4 February 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 243 (1) , 6-12
- https://doi.org/10.1006/bbrc.1997.8059
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Gene Transfer into Marrow Repopulating Cells: Comparison Between Amphotropic and Gibbon Ape Leukemia Virus Pseudotyped Retroviral Vectors in a Competitive Repopulation Assay in BaboonsBlood, 1997
- Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Breast Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, TexasHuman Gene Therapy, 1996
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- The current status of gene therapy using hematopoietic stem cellsCurrent Opinion in Pediatrics, 1995
- Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transferBlood, 1995
- Human MDR Gene Transfer in Patients with Advanced Cancer. Columbia University, New York, New YorkHuman Gene Therapy, 1994
- Retroviral Mediated Transfer of the Human Multidrug Resistance Gene (MDR-1) into Hematopoietic Stem Cells During Autologous Transplantation after Intensive Chemotherapy for Metastatic Breast Cancer. National Institutes of Health, Bethesda, MarylandHuman Gene Therapy, 1994
- Transfer and expression of the human multiple drug resistance gene into live mice.Proceedings of the National Academy of Sciences, 1992
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cellsNature, 1986